Quest Diagnostics (DGX) Free Cash Flow (2009 - 2026)

Quest Diagnostics (DGX) has 18 years of Free Cash Flow data on file, last reported at $164.0 million in Q1 2026.

• Quarterly Free Cash Flow fell 16.75% year-over-year to $164.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.3 billion (up 25.57% YoY) and the FY2025 annual result came in at $1.4 billion, up 49.5% from the prior year.
• Free Cash Flow slipped to $164.0 million in Q1 2026 per DGX's latest filing, from $307.0 million in the prior quarter.
• The five-year high for Free Cash Flow was $455.0 million in Q4 2023, with the low at -$33.0 million in Q1 2023.
• Average Free Cash Flow over 5 years is $271.2 million, with a median of $307.0 million recorded in 2025.
• Year-over-year, Free Cash Flow slumped 107.91% in 2023 and surged 294.0% in 2025.
• Quest Diagnostics' Free Cash Flow stood at $187.0 million in 2022, then jumped by 143.32% to $455.0 million in 2023, then fell by 25.05% to $341.0 million in 2024, then retreated by 9.97% to $307.0 million in 2025, then slumped by 46.58% to $164.0 million in 2026.
• Business Quant data shows DGX's Free Cash Flow at $164.0 million in Q1 2026, $307.0 million in Q4 2025, and $419.0 million in Q3 2025.